1-3 of 3
Susan M Richards, Ph.D
Close
Sort by
Journal Articles

UKALL 2003, A Randomised Trial Investigating Treatment Intensification for Children and Young Adults with Minimal Residual Disease Defined High Risk Acute Lymphoblastic Leukaema

Ajay J Vora, FRCPath, Nicholas Goulden, FRCPath, Christopher D Mitchell, FRCPCH, Rachael Hough, FRCPath, Clare Rowntree, FRCPath, Susan M Richards, Ph.D
Journal: Blood
Blood (2012) 120 (21): 136.
https://doi.org/10.1182/blood.V120.21.136.136
Published: 2012
Journal Articles

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

Jacob M. Rowe, MD, Georgina Buck, Anthony V Moorman, MD, Martin S Tallman, MD, Susan M Richards, Ph.D, Adele K Fielding, MD, Ph.D, Alan K. Burnett, MD, FRCP, Ian M Franklin, MD, Peter H. Wiernik, MD, Hillard M Lazarus, MD, Elisabeth Paietta, PhD, Mark R. Litzow, MD, David I Marks, MD, Selina Luger, MD, Gordon W. Dewald, PhD, PhD, FACMG, Anthony H. Goldstone, FRCP, FRCPath
Journal: Blood
Blood (2008) 112 (11): 3314.
https://doi.org/10.1182/blood.V112.11.3314.3314
Published: 2008
Journal Articles

Anti-Murine Thymocyte Globulin Prevents Acute Graft-Versus-Host Disease and Induces Foxp3+ T Cells in Target Organs.

Melanie C. Ruzek, PhD, James S. Waire, M.S., William Weber, B.S., John M. Williams, Ph.D., Susan M. Richards, Ph.D., Richard D. Garman, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3251.
https://doi.org/10.1182/blood.V110.11.3251.3251
Published: 2007